1/1

2 files

Cost-effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland

media

posted on 2020-06-08, 11:15 authored by Erkki Soini, Outi Virtanen, Saku Väätäinen, Jean-Baptiste Briere, Kevin Bowrin, Aurelie Millier

The above summary slide and plain language summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.

History

References

https://link.springer.com/article/10.1007/s12325-020-01398-8

Usage metrics

Read the peer-reviewed publication

Cost-effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland

Advances in Therapy

Advances in Therapy

Categories

Keywords

Acetylsalicylic acid Cardiovascular disease Chronic coronary syndrome Coronary artery disease Cost-benefit analysis Cost-effectiveness analysis Economic evaluation Peripheral artery disease Rivaroxaban Symptomatic Plain Language Summary

Licence

Exports